Cancers
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Pharmacologic Resistance in Soft Tissue Sarcomas: Mechanisms, Biomarkers, and Translational Therapeutic Strategies.
18.
2026
-
Programmed Death-Ligand 1 Expression in Triple-Negative Breast Cancer: Insights from a Mexican Cohort.
18.
2026
-
Correction: Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior (Cancers, (2021), 13, 24, (6256), 10.3390/cancers13246256).
18.
2026
-
Correction: Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior (Cancers, (2021), 13, 24, (6256), 10.3390/cancers13246256).
17.
2025
-
The Impact of Mutational Hotspots on Cancer Survival.
16.
2024
-
Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies.
15.
2023
-
Sphingolipids and Lymphomas: A Double-Edged Sword.
14.
2022
-
Biorecognition Engineering Technologies for Cancer Diagnosis: A Systematic Literature Review of Non-Conventional and Plausible Sensor Development Methods.
14.
2022
-
Germline Variants in Cancer Genes from Young Breast Cancer Mexican Patients.
14.
2022
-
Immune milieu and genomic alterations set the triple-negative breast cancer immunomodulatory subtype tumor behavior.
13.
2021
-
Intrinsic interferon signaling regulates the cell death and mesenchymal phenotype of glioblastoma stem cells.
13.
2021
-
Contrast-enhanced mammography for screening women after breast conserving surgery.
12:1-14.
2020
-
Unsupervised hierarchical clustering of pancreatic adenocarcinoma dataset from TCGA defines a mucin expression profile that impacts overall survival.
12:1-17.
2020
Identity
International Standard Serial Number (ISSN)